THERAPEUTIC CYTOKINES AND METHODS

RECOMBINANT ADENOVIRUSES AND USES THEREOF

CLUSTERIN OVEREXPRESSION IN ALZHEIMER’S DISEASE

CHIMERIC ANTIGEN RECEPTOR MODIFIED REGULATORY T CELLS FOR TREATING CANCER

ALTERING CYTOKINE SPECIFICITY THROUGH BINDING VALENCY

Recombinant adenoviruses and uses thereof

BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS

Interleukin-9 Signaling in Chimeric Antigen Receptor (CAR) Immune Cells

MODULATING GAMMA-C-CYTOKINE ACTIVITY

T CELL RECEPTORS AND METHODS OF USE THEREOF

T CELL RECEPTORS AND METHODS OF USE THEREOF

Recombinant adenoviruses and uses thereof

Expression of metabolic modulators in tumor microenvironment to improve tumor therapy

CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF

Modulating gamma-c-cytokine activity

Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11

Modulators of gamma-C-cytokine activity

Modulating gamma-C-cytokine activity

Compositions of GM-CSF and interleukin fusions for immune modulation and uses related thereto

Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein

CONJUGATES OF GM-CSF AND IL-9, COMPOSITIONS AND METHODS RELATED THERETO

DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS

Cysteine variants of interferon gamma

Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders

Interleukin-9 Antagonist Muteins and Their Pharmacological Methods of Use

DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS

Cysteine variants of interferon gamma

Cysteine variants of interferon-gamma

Interleukin-9 mutein peptides

Cysteine substitution variants of beta interferon

COOH-terminally added cysteine variant of the beta interferon

Cysteine variants of erythropoietin

Cysteine variants of erythropoietin